1. Home
  2. PAHC vs VCEL Comparison

PAHC vs VCEL Comparison

Compare PAHC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • VCEL
  • Stock Information
  • Founded
  • PAHC 1946
  • VCEL 1989
  • Country
  • PAHC United States
  • VCEL United States
  • Employees
  • PAHC N/A
  • VCEL N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PAHC Health Care
  • VCEL Health Care
  • Exchange
  • PAHC Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • PAHC 1.5B
  • VCEL 1.8B
  • IPO Year
  • PAHC 2014
  • VCEL 1997
  • Fundamental
  • Price
  • PAHC $44.48
  • VCEL $39.43
  • Analyst Decision
  • PAHC Hold
  • VCEL Strong Buy
  • Analyst Count
  • PAHC 4
  • VCEL 6
  • Target Price
  • PAHC $31.25
  • VCEL $60.40
  • AVG Volume (30 Days)
  • PAHC 324.6K
  • VCEL 626.8K
  • Earning Date
  • PAHC 11-05-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • PAHC 1.06%
  • VCEL N/A
  • EPS Growth
  • PAHC 288.74
  • VCEL 236.54
  • EPS
  • PAHC 1.67
  • VCEL 0.25
  • Revenue
  • PAHC $1,399,676,000.00
  • VCEL $258,716,999.00
  • Revenue This Year
  • PAHC $14.80
  • VCEL $18.35
  • Revenue Next Year
  • PAHC $3.16
  • VCEL $22.26
  • P/E Ratio
  • PAHC $27.13
  • VCEL $159.88
  • Revenue Growth
  • PAHC 33.72
  • VCEL 14.05
  • 52 Week Low
  • PAHC $16.16
  • VCEL $29.24
  • 52 Week High
  • PAHC $46.42
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 62.55
  • VCEL 61.62
  • Support Level
  • PAHC $43.71
  • VCEL $39.24
  • Resistance Level
  • PAHC $44.00
  • VCEL $41.66
  • Average True Range (ATR)
  • PAHC 2.15
  • VCEL 1.87
  • MACD
  • PAHC 0.08
  • VCEL 0.21
  • Stochastic Oscillator
  • PAHC 73.40
  • VCEL 61.56

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: